Stevanato Group S.p.A. (STVN) Stock

HealthcareMedical Instruments & Supplies Website

Company insiders reported 0 open-market buys and 4 sales on SEC Form 4 in the 90 days to Oct 21, 2026.

Are Stevanato Group S.p.A. insiders buying or selling?

SEC Form 4 filings
90 days to Oct 21, 2026
Buys
0
Sells
4
Net $
-$460K
Unique insiders
4
DateInsiderRoleTypeSharesValue
Sep 28, 26Stocchi MauroSee RemarksSELL13.6K$293K
Aug 7, 26Magistretti ElisabettaDirectorSELL2.0K$41K
Aug 7, 26Dal Lago MarcoChief Financial OfficerSELL4.2K$85K
Aug 7, 26Santel LucianoDirectorSELL2.0K$41K

SEC Form 4 filings as of Oct 21, 2026

See cluster-buy signals across all tickers →

STVN price chart

Powered by TradingView

What does Stevanato Group S.p.A. do?

Stevanato Group S.p.A. is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The company offers an integrated portfolio of products, processes, and services that support customers across the entire drug life cycle, from development and clinical stages to commercial production. Its Biopharmaceutical and Diagnostic Solutions segment provides glass primary packaging such as vials, cartridges, syringes, and ampoules, alongside plastic components for drug delivery systems and in-vitro diagnostic consumables. The Engineering segment delivers specialized equipment including visual inspection systems, assembly lines, glass converting machinery, secondary packaging solutions, and analytical services to ensure product quality and regulatory compliance. Stevanato Group S.p.A. emphasizes technological innovation, manufacturing excellence, and a global footprint with production sites in multiple countries. Founded in 1949 and headquartered in Piombino Dese, Padua, Italy, it serves major players in the biopharmaceutical sector with end-to-end solutions for injectable drugs and diagnostic applications.

CEO
Mr. Franco Stevanato
Employees
6,010
Ask about STVNAI research agent